首页> 外国专利> use of immunotoxinen to trigger an immune tolerance in transplantation of islet cells in the pancreas.

use of immunotoxinen to trigger an immune tolerance in transplantation of islet cells in the pancreas.

机译:在胰腺胰岛细胞移植中使用免疫毒素来引发免疫耐受。

摘要

The invention provides a method of treating diabetes in a subject, comprising administering to the diabetic subject an immunotoxin, thereby reducing the subject's T-cell population, and administering to the subject pancreatic islet cells from a donor. The immune tolerance inducing treatment regimen, used optionally with adjunct immunosuppressive agents, prevents pancreatic islet cell rejection while maintaining long term islet cell function following xenogeneic and allogeneic pancreatic islet cell transplantation. Thus, the methods of the present invention provide a means for treating diabetes, wherein the need for exogenous insulin or immunosuppressive agents is decreased or eliminated. Also provided is a method of inhibiting a rejection response of a transplant recipient, comprising administering an immunotoxin during the peritransplant period, thereby transiently reducing the number of T-cell lymphocytes and promoting long-term survival of the transplant.
机译:本发明提供了一种在受试者中治疗糖尿病的方法,该方法包括对糖尿病受试者施用免疫毒素,从而减少受试者的T细胞群,以及对来自供体的胰腺胰岛细胞进行给药。异种和同种异体胰岛细胞移植后,诱导免疫耐受的治疗方案(可选地与辅助免疫抑制剂配合使用)可防止胰岛细胞排斥,同时保持长期的胰岛细胞功能。因此,本发明的方法提供了一种治疗糖尿病的方法,其中减少或消除了对外源胰岛素或免疫抑制剂的需要。还提供了一种抑制移植受体的排斥反应的方法,该方法包括在移植期周围施用免疫毒素,从而瞬时减少T细胞淋巴细胞的数量并促进移植的长期存活。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号